novel precision drugs that target the tumor microenvironment
“I declare war on cancer stroma”

LAUREANO SIMON, Oncomatryx CEO, declares war on tumor microenvironment. “We envision a new era where cancer in general and invasive tumors in particular will be beaten with orchestrated combinations of precision